Skip to content
Publish & Distribute
Publishing Solutions
Distribution Solutions
Library Services
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Journal Matcher
Blog
Contact
Search
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Radiology and Oncology
Volume 52 (2018): Issue 4 (December 2018)
Open Access
Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cells
Tanja Mesti
Tanja Mesti
Laboratoire de Recherches Biochirurgicales, Université Paris Descartes, Hôpital Européen Georges Pompidou
paris, France
Division of Medical Oncology, Institute of Oncology Ljubljana
Ljubljana, Slovenia
Search for this author on
Sciendo
|
Google Scholar
Mesti, Tanja
,
Nadia Bouchemal
Nadia Bouchemal
CSPBAT, UMR 7244, CNRS, Université Paris 13
Bobigny, France
Search for this author on
Sciendo
|
Google Scholar
Bouchemal, Nadia
,
Claire Banissi
Claire Banissi
Laboratoire de Recherches Biochirurgicales, Université Paris Descartes, Hôpital Européen Georges Pompidou
paris, France
Search for this author on
Sciendo
|
Google Scholar
Banissi, Claire
,
Mohamed N. Triba
Mohamed N. Triba
CSPBAT, UMR 7244, CNRS, Université Paris 13
Bobigny, France
Search for this author on
Sciendo
|
Google Scholar
Triba, Mohamed N.
,
Carole Marbeuf-Gueye
Carole Marbeuf-Gueye
CSPBAT, UMR 7244, CNRS, Université Paris 13
Bobigny, France
Search for this author on
Sciendo
|
Google Scholar
Marbeuf-Gueye, Carole
,
Maja Cemazar
Maja Cemazar
Department of Experimental Oncology, Institute of Oncology Ljubljana
Ljubljana, Slovenia
Search for this author on
Sciendo
|
Google Scholar
Cemazar, Maja
,
Laurence Le Moyec
Laurence Le Moyec
Unité de Biologie Intégrative des Adaptations à l’Exercice, Université d’Evry
Evry, France
Search for this author on
Sciendo
|
Google Scholar
Moyec, Laurence Le
,
Antoine F. Carpentier
Antoine F. Carpentier
Laboratoire de Recherches Biochirurgicales, Université Paris Descartes, Hôpital Européen Georges Pompidou
paris, France
Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne, Service de Neurologie
Bobigny, France
Search for this author on
Sciendo
|
Google Scholar
Carpentier, Antoine F.
,
Philippe Savarin
Philippe Savarin
Department of Experimental Oncology, Institute of Oncology Ljubljana
Ljubljana, Slovenia
Search for this author on
Sciendo
|
Google Scholar
Savarin, Philippe
and
Janja Ocvirk
Janja Ocvirk
Division of Medical Oncology, Institute of Oncology Ljubljana
Ljubljana, Slovenia
Search for this author on
Sciendo
|
Google Scholar
Ocvirk, Janja
Nov 26, 2018
Radiology and Oncology
Volume 52 (2018): Issue 4 (December 2018)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Download Cover
Article Category:
Research Article
Published Online:
Nov 26, 2018
Page range:
392 - 398
Received:
Nov 30, 2017
Accepted:
Oct 21, 2018
DOI:
https://doi.org/10.2478/raon-2018-0046
Keywords
idh1 mutation
,
malignant glioma
,
bevacizumab
,
metabolic
,
fingerprint
© 2018 Tanja Mesti, Nadia Bouchemal, Claire Banissi, Mohamed N. Triba, Carole Marbeuf-Gueye, Maja Cemazar, Laurence Le Moyec, Antoine F. Carpentier,Philippe Savarin, Janja Ocvirk, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
